DIAGNOSTIC AND PREDICTIVE POTENTIAL OF THE C-REACTIVE PROTEIN IN SERUM AND ASCITES FOR SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS AND ASCITES
Abstract
Spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis is a spontaneous bacterial infection of sterile ascites fluid in the absence of intra-abdominal sources of infection or malignancy. The purpose of the study is to determine the diagnostic and predictive potential of CRP in serum and ascites, as an inflammatory indicator of SBP in patients with liver cirrhosis and ascites and to compare the mean values of CRP in serum and ascites in patients with and without SBP. In this prospective-observational study were included 70 patients with cirrhosis and ascites, divided into two groups, SBP and non-SBP group. Quantitative measurement of CRP in serum and ascites was determined by immunoturbidimetric method using latex particles. The average value of CRP in serum in SBP group was 35.4 ± 29.51 mg / L, and in control non-SBP group it was lower (18.6 ± 18.71 mg/L), and this difference was statistically significant for p = 0.006132. The average value of CRP in ascites in SBP group was 7.3 ± 7.2, and in non-SBP group it was lower (2.9 ± 3.1l), with statistically significant difference of p = 0.001604. ROC analysis indicates that CRP contributes to the diagnosis of SBP with 71.0% (p = 0.003) (good predictor). Univariate analysis showed that serum CRP> 6 mg / L and CRP in ascites> 6 mg / L significantly increased the chance of SBP by seven times (Exp (B) = 7,319) and three times (Exp (B) = 3,059), respectively. Our research confirmed that serum CRP is a good predictor, significantly associated with the occurrence of SBP in patients with liver cirrhosis.
Keywords: SBP, C-reactive protein, ascites, liver cirrhosis
References
peritonitis: a consensus document. JHepatol 2000 Jan;32(1):142-53.
2. Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitisor portal
hypertension? How do I perform a paracentesis and analyze the results? JAMA 2008 Mar 12;299(10):1166-78.
3. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and wider. Gut 2012 Feb
1;61(2):297-310.
4. Piano S, Singh V, Caraceni P, et al. Epidemiology, predictors and outcomes of multi drug resistant (MDR)
bacterial infections in patients with cirrhosis across the world. Final results of the “Global study†Dig Liver Dis
2018;50(1):2–3.
5. Marciano S, et al. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and
treatment strategies. Hepat Med 2019; 11: 13–22.
6. Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: a literature review.
World J Hepatol 2018;10(2):254–266.
7. Mendall MA, Strachan D, Butland BK, et al. C-reactive protein: Relation to total mortality, cardiovascular
mortality and cardiovascular risk factors in men. Eur Heart J 2000 Oct;21(19):1584-90.
8. Imhof A, Froehlich M, Boeing H, et al. Effect of alcohol consumption on systemic markers of inflammation.
Lancet 2001 Mar 10;357(9258):763–7.
9. Hirschfield GM, Pepys M. C-reactive protein and cardiovascular disease: new insights from an old molecule.
Q J Med 2003 Nov;96(11):793–807.
10. Westhuyzen J, Healy H. Review: Biology and relevance of C-reactive protein in cardiovascular and renal
disease. Ann Clin Lab Sci 2000 Apr;30(2):133–43.
11. Vigushin DM, Pepys M, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human c-reactive
protein in health and disease. J Clin Invest 1993 Apr;91(4):1351–7.
12. Kadam N, Acharya S, Shukla S, Gupta K. Ascitic fluid high sensitive C-reactive protein (hs-CRP). A prognostic
marker in cirrhosis with spontaneous bacterial peritonitis. J Clin Diagn Res 2016 Apr;10(4):OC20–OC24.
13. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a
systematic review of 118 studies. J Hepatol 2006;44(1):217–231.
14. Kadam N, Acharya S, Shukla S, Gupta K. Ascitic fluid high sensitive C-reactive protein (hs-CRP). A prognostic
marker in cirrhosis with spontaneous bacterial peritonitis. J Clin Diagn Res 2016 Apr;10(4):OC20–OC24.
15. Viallon A, Zeni F, Puozet V, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous
bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med
2000 Aug;26(8):1082-8.
16. Preto-Zamperlini M, Farhat SC, Perondi MB, et al. Elevated C-reactive protein and spontaneous bacterial
peritonitis in children with chronic liver disease and ascites. J Pediatr Gastroenterol Nutr 2014 Jan; 58(1):96-8.
17. Pieri G, Agarwal B and Burroughsa A.K. C-reactive protein and bacterial infection in cirrhosis. Ann
Gastroenterol 2014; 27(2): 113–120.
18. Yuan LY, Ke ZQ, M.D, Wang M, et al. Procalcitonin and C-reactive protein in the diagnosis and prediction of
spontaneous bacterial peritonitis associated with chronic severe hepatitis B.Ann Lab Med 2013;33:449-454.
19. Abdel-Razik A, Eldars W, Rizk E. Platelet indices and inflammatory markers as diagnostic predictors for ascitic
fluid infection. Eur J Gastroenterol Hepatol 2014 Dec;26(12):1342–7.
20. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in
critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005 Dec; 146(6): 347-51.
21. Runyon B.A.Ascitic fluid and serum C-reactive protein concentrations in patients with and without
peritonitis. AmJ Clin Pathol 1986 Dec;86(6):773-775.
22. Weil D, Heurgue-Berlot A, Monnet E et al. Accuracy of calprotectin using the Quantum Blue Reader for the
diagnosis of spontaneous bacterial peritonitis in liver cirrhosis. Hepatology Research. 2019 Jan;49(1):72-81
